No known interaction with other equine medicaments.

Studies in other species showed no teratogenic or embryotoxic effect from either ivermectin or praziquantel at the recommended doses during therapy.

A tolerance study performed in foals from 2 weeks of age with doses up to 5 times the recommended dosage showed no adverse reactions.

Safety studies conducted with Equimax administered to mares at 3 times the recommended dosage at 14 day intervals during the whole gestation and lactation did not show any abortions, any adverse effects on the gestation, parturition and on the mares general health, nor any abnormalities on the foals.

Safety studies conducted with Equimax administered to stallions at 3 times the recommended dosage did not show any adverse effects in particular on the reproductive performances.